# COMPLERA

NDC: 61958-1101
Generic name: emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate
Labeler / Manufacturer: Gilead Sciences, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20110810

FDA application: NDA202123

## Active ingredients

- EMTRICITABINE: 200 mg/1
- RILPIVIRINE HYDROCHLORIDE: 25 mg/1
- TENOFOVIR DISOPROXIL FUMARATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61958-1101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61958-1101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d637cfab-f1e8-4eb3-a1b3-f85ca3bec612